NCT00040950View on ClinicalTrials.gov

Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2002

Study Completion Date

October 31, 2007

Conditions

Lymphoma

Interventions

BIOLOGICAL

rituximab

DRUG

agatolimod sodium

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00040950 - Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter